NCVHS' Recommendations Regarding Privacy Rule's Effect on Banking
June 17, 2004
The Honorable Tommy G. Thompson
Secretary
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201
Dear Secretary Thompson:
As part of its responsibilities under the Health Insurance Portability
and Accountability Act of 1996 (HIPAA), the National Committee on
Vital and Health Statistics (NCVHS) monitors the implementation
of the Administrative Simplification provisions of HIPAA, including
the Standards for Privacy of Individually Identifiable Health Information
(Privacy Rule).
The NCVHS Subcommittee on Privacy and Confidentiality held hearings
in Washington, DC on February 18-19, 2004. The hearings, the second
of several to be held on HIPAA implementation, were intended to
gather information about the effect of the Privacy Rule in three
areas: banking, law enforcement, and schools. Additional hearings
will address other aspects of HIPAA implementation. This letter
conveys the Committee’s findings and recommendations for action
by the Department regarding banking. Separate letters contain findings
and recommendations regarding law enforcement, and schools.
Representatives from a broad range of backgrounds testified about
the effect of the Privacy Rule on banking, including representatives
with extensive technical knowledge of health care information and
bank processing, health care clearinghouses, electronic privacy
issues, and confidentiality provisions contained in federal laws
applicable to financial institutions.
HIPAA provides that its standards shall not apply to financial
institutions engaged in banking functions, including functions that
might involve use or disclosure of information about patients (see
Social Security Act, Section 1179, 42 U.S.C. 1320d-8). Although
the vast majority of health care information processing activities
performed by financial institutions fall under this exception, there
are circumstances under which financial institutions perform services
not covered by the exception. For example, a small number of banks
are clearinghouses as a result of services provided in addition
to processing payments in their financial institution capacity,
and are thus covered entities under HIPAA.
A critical issue is whether other privacy laws adequately protect
health information held by financial institutions exempt from HIPAA
under Section 1179. A witness from Georgetown University’s
Health Policy Institute testified that other laws do not adequately
protect personal health information held by financial institutions.
Neither the Gramm-Leach-Bliley Act (also known as the Financial
Services Modernization Act), nor the recent amendments to the Fair
Credit Reporting Act made by the Fair and Accurate Credit Transactions
Act (FACT Act) provide protection. The Gramm-Leach-Bliley Act was
intended to facilitate the integration of banks and other financial
institutions, which involves sharing consumer information. Generally,
the FACT Act prohibits a bank and other creditors from obtaining
and using health information for consumer-credit decision purposes.
Regulations for the FACT Act are under development.
A witness from the American Bankers Association (ABA) testified
that financial institutions are very diligent about protecting consumers’
personal financial and medical information. The ABA and the National
Automated Clearinghouse Association (NACHA) developed educational
materials to help financial institutions prepare for the implementation
of the HIPAA Privacy Rule. The ABA has recommended to financial
institutions that they participate in and execute business associate
agreements when they are engaged in health care processing. The
Medical Banking Project (Project) testified that a number of financial
institutions have inquired about HIPAA business associate agreements
and thus it is the sense of the Project that financial institutions
are executing and signing the agreements when asked to do so.
A witness from the Electronic Privacy Information Center (EPIC)
expressed several concerns about financial institutions and the
privacy of personal health information. EPIC does not support the
Section 1179 exception for financial institutions that handle protected
health information (PHI) contained in premium payment and remittance
advice transactions. EPIC believes such entities should have covered
entity status as health care clearinghouses under the Privacy Rule.
EPIC does not believe that business associate agreements provide
the same level of protection for health information as covered entity
status. Also, the EPIC witness discussed the problems associated
with transmitting PHI through the banking system’s automated
clearing house (ACH) network. EPIC suggested that when PHI moves
through the ACH, it be encrypted so that it is accessible only by
the final recipient. Encryption also would help provide protection
in the event of network security breaches as well as prevent potential
data mining for marketing purposes.
NCVHS notes that the banking industry is evolving and diversifying
its services for the processing of personal health information.
For example, financial institutions have begun to acquire health
care clearinghouses, and they provide value-added services that
potentially involve personal health information. Financial institutions
face new privacy challenges and responsibilities in today’s
environment and with that in mind, the NCVHS recommends the following:
HHS should clarify the nature of the Section 1179 exception for
financial institutions when engaged in processing health care transactions.
Specifically, clarification is needed from HHS about whether the
exception applies to consumer-initiated transactions (e.g., credit
card or check payments), covered entity-initiated payment transactions,
or both.
Until HHS clarifies the Section 1179 exception, HHS should recommend
to health care providers and payers that they use business associate
agreements with financial institutions.
Regardless of the technical status of financial institutions under
the law and the regulation, HHS should consider whether encryption
should be required for PHI moving through the ACH, to ensure that
it is available only to final recipients.
We appreciate the opportunity to offer these comments and recommendations.
Sincerely,
/s/
John R. Lumpkin, M.D., M.P.H.
Chairman, National Committee on Vital and Health Statistics
Cc: HHS Data Council Co-Chairs
|